11th Jan 2006

AlignRT, a revolutionary solution for real-time patient positioning and tracking, has just received 510(k) clearance from the FDA. The AlignRT product, showcased at the ASTRO 2005 meeting in Denver, may now be marketed as a class II medical device in the USA. “This is a significant achievement for Vision RT as it opens the doors of the world’s largest radiotherapy market”, says Dr Norman Smith, CEO of Vision RT.

AlignRT is a real-time 3D patient tracking system and may be used for both patient setup and monitoring. For more information on the AlignRT product go to Vision RT’s website at www.visionrt.com.

AlignRT® on display at ASTRO 2005, Denver, Colorado.